Trump Officials Met With Walmart on Direct-to-Patient Drug Sales

US health officials met with with Walmart Inc., Amazon.com Inc. and other retailers this week as part of an effort to help Americans get their medicines more directly from companies that make them, according to people familiar with the talks.

The conversations between the Trump administration and experts from the nascent straight-to-consumer drug industry are intended to explore streamlining the way Americans get their medicines and therefore lower costs, said the people, who weren’t authorized to speak publicly on the matter.